跳至主要内容
临床试验/NCT02202941
NCT02202941已完成不适用

Effect of Procalcitonin-guided Treatment on Duration of Antibiotic Therapy and Cost in Septic Patients in Korea

Seoul National University Hospital6 个研究点 分布在 1 个国家目标入组 62 人开始时间: 2014年8月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
62
试验地点
6
主要终点
Duration of antibiotic treatment

研究概览

简要总结

This clinical trial is aimed to show a procalcitonin-guided treatment algorithm may shorten duration of antibiotic therapy safely and cost-effectively in sepsis patients of Korean ICU.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
19 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All patients with suspicious or confirmed sepsis at admission or during stay in ICU
  • Patients with antibiotic duration of less than 48 hours before enrollment

排除标准

  • Age less than or equal to 18 years
  • Known pregnancy
  • Specific infections for which long-term antibiotic treatment for 3 weeks more is strongly recommended: infective endocarditis, empyema, osteomyelitis et al.
  • severe immunocompromised patients : HIV infected patients (CD4 count < 200 cells/mm3), Neutropenia (ANC count < 500/mm3)
  • Presence of do-not-resuscitate order

研究组 & 干预措施

Procalcitonin guided treatment

Experimental

Patients who will be randomized to this arm will receive antibiotics therapy based on procalcitonin-guided algorithm.

干预措施: Procalcitonin guided treatment (Other)

Conventional treatment

Active Comparator

Patients who will be randomized to this arm will receive antibiotic therapy based on conventional practice.

干预措施: Conventional treatment (Other)

结局指标

主要结局

Duration of antibiotic treatment

时间窗: up to 28 days

次要结局

  • Clinical response to treatment for infection(up to 28 days)
  • In hospital mortality(up to 90 days)
  • All cause mortality(up to 28 days)
  • In ICU mortality(up to 28 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sang-Min Lee

Associate professor

Seoul National University Hospital

研究点 (6)

Loading locations...

相似试验